Background: decongestants whether systemic or topical nasal are widely used in the treatment of acute otitis media but there is still controversy about their effectiveness. The aim of this study is to evaluate the effectiveness of topical nasal decongestants in the treatment of acute otitis media and their role in the resolution of middle ear effusion after acute otitis media attack. Subject and Methods: The current study involved 100 children ranging from 4-12 years of both sexes with acute otitis media that need antibiotics in treatment and the study done in Rizgary teaching hospital in Erbil during the period of 2015-2017. Patients subsequently divided into two groups for treatment. Group A treated with oral co-amoxiclav, oral paracetamol, and topical nasal xylometazoline drop. Group B treated with the same antibiotic but without topical nasal xylometazoline drop. The children are followed up three months by 5 visits; in the first and second follow up visits the children are examined clinically for the improvement in the signs and symptoms of acute infection. In the last three visits the children are followed up for the resolution of middle ear effusion by otoscopic examination and tympanometry test. Pure Tone Audiometry (PTA) test done for children in the first and fifth visits, to know the hearing gain between the two visits and the difference between group A and group B. Results: The mean age + SD of the children were 7.26 + 2.4 years, ranging from 4 to 12 years. The median was 7 years. 58% of the patients were boys and 42% were girls. In the first visit, we found better results in group A that was near significant for pain relief (p=0.067). During subsequent visits we found good resolution in both groups with non significant better results in group A. Conclusions: there is no significant benefit from the use of topical nasal decongestant in the treatment of AOM.
cute otitis media (AOM) is a common presenting illness encountering general practitioners, pediatricians, and otolaryngologists. Predominantly acute otitis media is a childhood disease, but also occurs in adults. Most of the children suffer from at least one attack of AOM during their life 1, 2 . Acute otitis media can be defined as sudden onset of signs and symptoms of inflammation in the middle ear cleft mucosa associated with middle ear The physiological importance of Eustachian tube (ET) for middle ear is pressure regulation, protection, and drainage. The Eustachian tube is shorter, wider, and more horizontal in children, which is one of the reasons that AOM is more common in children 2, 3 . AOM is common in cold seasons (especially in autumn and winter) and commonly is following an attack of Upper Respiratory Infections (URTI) 2, 4 .URTI causes congestion of the nasal and nasopharyngeal mucosa and around the nasopharyngeal orifice of the ET, this leads to a poorly functional tube and the dysfunctional ET plays a role in the development of the AOM 4,5 , so decongestants are commonly used because of their effects on nasal congestion, and their role in the function of the ET 3, 6 ,and that is the aim of the study to evaluate the effect of topical nasal decongestant in the treatment of AOM and whether they have a role in the resolution of middle ear effusion. Topical nasal decongestants are fast-acting drugs which are potently effective for the reduction of nasal congestion. Xylometazoline (Imidazolines group) achieve their decongestive effect via activation of α-adrenergic receptors, resulting in vasoconstriction of the blood vessels and, consequently, resumption of nasal airflow 7, 8 .The diagnosis of AOM is usually difficult; there are no standard criteria and no specific laboratory tests 9 .
The clinical signs of highest predictive value are bulging eardrum, clouding of the eardrum, reduced eardrum mobility, and hearing loss these signs indicate middle ear inflammation and effusion 5, 9 . Pneumatic otoscope and tympanometry can be used to confirm middle ear effusion 5, 9, 10 .
Usually, AOM is a self-limited disease, in most instances it resolves spontaneously; however, some cases need antibiotics. Decongestants and antihistamines can be prescribed in the treatment of AOM, although, they are not proven to be effective 2, 4,5
. 
PATIENTS AND METHODS

RESULTS
Two groups of children participated in the study, 50 children in each group. Group A was given an antibiotic (AB) and a topical nasal decongestant (xylometazoline), and Group B was given antibiotic only. The mean age + SD of the children were 7.26 + 2.4 years, ranging from 4 to 12 years. The median was 7 years. The mean age + SD of group A was 7.44 + 2.54, and that of Group B was 7.08 + 2.27 years (p= 0.457). Table 1 , shows that around half (45%) of the whole sample aged 4-6 years, with no significant difference in the age distribution of the two groups (p = 0.730). The table shows also that 58% of each group were males (p =1). During the second visit (Table 3) the pain and fever disappeared, but 32% of each of the groups had tympanic membrane congestion, and middle ear effusion. In group A 19 patients were free of effusion (recovery rate 38%) and group B 13 patients had type Atympanometry (recovery rate 26%). The correlation between them is not significant p-value= 0.198 and the recovery rate of the whole sample during the second follow up visit is 32%. In the first visit we found better results with the group A especially for pain. The difference between the two groups was near significant level (p = 0.067) for pain but far from significance for other signs and symptoms and the recovery rate was very low in both group. The study done by 4foundsignificant better outcome for group A during first visit, but also concluded that in long term duration there is no difference from the use of decongestants and antihistamines in the treatment of AOM.
There is an old study done by Schnore et al, 1986 14 , they found no difference in relief of pain between the two groups. In the 2 nd follow up visit pain and fever disappeared from both groups but congestion and effusion persist in some children and no statistical benefit found from decongestant although the results were better in decongestant group, and the recovery rate in this visit was 32% (38% in group A) and 26% in group B) in contrast emphasized that there is no benefit and some harm from the use of antihistamines or decongestants alone or in combination in the management of otitis media with effusion 18 . We also discovered that there is no significant difference from the use of topical nasal decongestant in the treatment of AOM.
In the present study we also did PTA for the children in the 1 st and 5 th follow up visits to know the mean hearing gain of each group after 3 months and to support our results. We didn't find any difference between the two groups mean hearing gain in group A was 11.1 dB, and that of group B was 10.9 dB (p = 0.840), and this is not done in any study previously. Rosenfeld and Kay, 2003 reported that an untreated AOM had a 59% resolution by one month and 74% resolution by three months 19 . The authors found that most children without risk factors for AOM and above two years old will recover without antibiotic therapy. Renko et al, 2006 reported better results with antibiotherapy, they showed that 69% of children with AOM treated with different antibiotics were free of middle ear effusion within 2 weeks 20 , in our study after 2 weeks 75% of children were free of middle ear effusion(78% in group A and 72% in group B) and after one month 86% of the patients had type A tympanogram (88% group A and 84% group B), so we found better resolution with antibiotics in compares to Renko et al, 2006 results although almost all our cases were sever AOM. In conclusion there is no long term benefit from the use of topical nasal decongestant in the treatment of AOM. 
